Versant Venture Capital IV L.P. 13D and 13G filings for CRISPR Therapeutics AG:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-09-18 5:05 pm Purchase |
2020-09-09 | 13D | CRISPR Therapeutics AG CRSP |
Versant Venture Capital IV L.P. | 2,087,120 3.000% |
2,087,120 (New Position) |
Filing |